ResMed Inc. vs BlackRock TCP Capital Corp — how do they compare? ResMed Inc. trades at $197.45 (market cap $28.81B), while BlackRock TCP Capital Corp trades at $3.24 (market cap $270.17M). The key difference: ResMed Inc. is far larger — about 106.6× BlackRock TCP Capital Corp's market cap, and BlackRock TCP Capital Corp pays the higher dividend (26.09%). Which is the better fit depends on your goals.
| RMD | TCPC | |
|---|---|---|
Market Cap | $28.81B | $270.17M |
Sector | Health | Financials |
52-Week High | $293.73 | $7.64 |
52-Week Low | $182.82 | $3.14 |
Enterprise Value | $27.99B | — |
Dividend Yield | 1.21% | 26.09% |
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →BlackRock TCP Capital Corp is a finance company specializing in middle-market lending. It aims for high returns through income and capital appreciation while prioritizing principal protection. The company invests in debt securities and earns revenue from interest payments, fees, and some equity appreciation.
Read more on TCPC →